-
Mashup Score: 0Your expertise is needed! - Rheuma - 9 month(s) ago
The ARA survey on the Australian quality standard for rheumatoid arthritis is now live.
Source: www.rheuma.com.auCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Patient perspectives on achieving remission - Rheuma - 11 month(s) ago
Doctors and patients should discuss how they each define remission before making any treatment goals or decisions.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
With advances in treatments for rheumatic and related conditions, having patients reach clinical remission is no longer a pipe dream. Does remission mean the same thing to drs and patients? @CreakyJointsAus https://t.co/7Yw5qS1RJC
-
-
Mashup Score: 0Novel knee-brace therapy success in ACL rupture - Rheuma - 11 month(s) ago
Australian research provides more evidence for non-surgical ACL treatment, with potential long-term benefits for osteoarthritis.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
A new Australian study by @stephfilbay adds to a small but growing body of evidence that ACL injuries can be successfully treated by non-surgical means. @KarinaBray7 https://t.co/cBAJOMClZE
-
-
Mashup Score: 0Do NSAIDs impact axSpA MRI performance? - Rheuma - 11 month(s) ago
UK study at EULAR 2023 looks at what time window is relevant.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Non-specific low back pain? Or axSpA? Taking NSAIDs for low back pain could mask inflammation in MRI @KarinaBray7 #EULAR2023 https://t.co/kfVFTw793e
-
-
Mashup Score: 0Rituximab a one-shot stop for PMR? - Rheuma - 1 year(s) ago
PMR benefit still apparent one year after a single dose of rituximab.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
An extension study of the BRIDGE-PMR trial has found that patients given a single 1000mg dose of rituximab remained in remission one year post-infusion - "promising" says @drceowen, but more research needed. @KarinaBray7 https://t.co/Ge5sjSnrTC
-
-
Mashup Score: 0Burnout in rheumos: it's all relative - Rheuma - 1 year(s) ago
While rheumatologists may report less burnout and higher resilience than some medical practitioners, that doesn’t mean there isn’t a problem.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Data suggests rheumos aren't doing too badly, at least compared with other specialties, but what was really striking was the rates of burnout in rheum trainees, says @BethanRichards3 @CateSwannellTMR https://t.co/0WeEeGk6r9
-
-
Mashup Score: 0Sex and gender in rheumatology: Summit roundup - Rheuma - 2 year(s) ago
There’s a lot to learn about how sex and gender play into disease manifestation and clinical care, says the editor-in-chief of The Lancet Rheumatology.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Thanks to Dr Heather Van Epps, editor-in-chief of @TheLancetRheum, for sharing her highlights and insights from the recent sex and gender summit. https://t.co/vBknX4Q1z4
-
-
Mashup Score: 0Triple therapy: the patients’ perspective - Rheuma - 2 year(s) ago
Multiple medications might seem daunting, but patients ultimately want what’s best for them.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
What’s the better treatment option for a patient with early, moderate RA who hasn’t been on DMARD therapy before? Triple therapy may seem daunting, but patients want what's best. @CreakyJointsAus @rosieainley https://t.co/G5MlivKJam
-
-
Mashup Score: 0There’s no best age to call it quits - Rheuma - 2 year(s) ago
When is it time for a rheumo to retire? The MBA has its sights on doctors 70 and over.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
Retirement should be a choice, but the MBA has its sights on doctors 70 and over. @BylineFrancis https://t.co/xQ854WusCj
-
-
Mashup Score: 0Let the rituximab flow - Rheuma - 2 year(s) ago
With today’s PBS schedule change, prominent rheums reflect on how general schedule listing changes practice.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet-
“This is game changing for Australians. It will improve access to a potentially lifesaving drug for people with chronic, incurable, systemic inflammatory diseases." @helenyu09 Prominent rheums reflect on rituximab unrestricted listing https://t.co/XpQ4i64J1s
-
🇦🇺Rheumos and RA patients, make sure you have your say! @AusRheum https://t.co/Hz2883XsEz